181 related articles for article (PubMed ID: 23462913)
1. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Supplementation Trials Aimed at Reducing Mortality Have Much Higher Power When Focusing on People with Low Serum 25-Hydroxyvitamin D Concentrations.
Brenner H; Jansen L; Saum KU; Holleczek B; Schöttker B
J Nutr; 2017 Jul; 147(7):1325-1333. PubMed ID: 28539415
[No Abstract] [Full Text] [Related]
3. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults.
Schöttker B; Herder C; Rothenbacher D; Perna L; Müller H; Brenner H
Eur J Epidemiol; 2013 Mar; 28(3):267-75. PubMed ID: 23354985
[TBL] [Abstract][Full Text] [Related]
4. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.
Schöttker B; Haug U; Schomburg L; Köhrle J; Perna L; Müller H; Holleczek B; Brenner H
Am J Clin Nutr; 2013 Apr; 97(4):782-93. PubMed ID: 23446902
[TBL] [Abstract][Full Text] [Related]
5. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
6. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
7. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.
Ginde AA; Scragg R; Schwartz RS; Camargo CA
J Am Geriatr Soc; 2009 Sep; 57(9):1595-603. PubMed ID: 19549021
[TBL] [Abstract][Full Text] [Related]
9. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
McDonnell SL; Baggerly CA; French CB; Baggerly LL; Garland CF; Gorham ED; Hollis BW; Trump DL; Lappe JM
PLoS One; 2018; 13(6):e0199265. PubMed ID: 29906273
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and cancer mortality in elderly women.
Wong G; Lim WH; Lewis J; Craig JC; Turner R; Zhu K; Lim EM; Prince R
BMC Cancer; 2015 Mar; 15():106. PubMed ID: 25884436
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of serum vitamin D and cancer mortality in the United States.
Freedman DM; Looker AC; Chang SC; Graubard BI
J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
[TBL] [Abstract][Full Text] [Related]
14. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer.
Skaaby T; Husemoen LL; Thuesen BH; Pisinger C; Jørgensen T; Roswall N; Larsen SC; Linneberg A
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1220-9. PubMed ID: 24789846
[TBL] [Abstract][Full Text] [Related]
15. Association of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and parathyroid hormone with mortality among middle-aged and older European men.
Lee DM; Vanderschueren D; Boonen S; O'Neill TW; Pendleton N; Pye SR; Ravindrarajah R; Gielen E; Claessens F; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Lean ME; Punab M; Wu FC;
Age Ageing; 2014 Jul; 43(4):528-35. PubMed ID: 24375224
[TBL] [Abstract][Full Text] [Related]
16. Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.
McDonnell SL; Baggerly C; French CB; Baggerly LL; Garland CF; Gorham ED; Lappe JM; Heaney RP
PLoS One; 2016; 11(4):e0152441. PubMed ID: 27049526
[TBL] [Abstract][Full Text] [Related]
17. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.
Ordóñez-Mena JM; Schöttker B; Fedirko V; Jenab M; Olsen A; Halkjær J; Kampman E; de Groot L; Jansen E; Bueno-de-Mesquita HB; Peeters PH; Siganos G; Wilsgaard T; Perna L; Holleczek B; Pettersson-Kymmer U; Orfanos P; Trichopoulou A; Boffetta P; Brenner H
Eur J Epidemiol; 2016 Mar; 31(3):311-23. PubMed ID: 25977096
[TBL] [Abstract][Full Text] [Related]
18. Serum 25-hydroxyvitamin D and incidence of fatal and nonfatal cardiovascular events: a prospective study with repeated measurements.
Perna L; Schöttker B; Holleczek B; Brenner H
J Clin Endocrinol Metab; 2013 Dec; 98(12):4908-15. PubMed ID: 24106288
[TBL] [Abstract][Full Text] [Related]
19. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.
Cheney CP; Thorand B; Huth C; Berger K; Peters A; Seifert-Klauss V; Kiechle M; Strauch K; Quante AS
Oncol Res Treat; 2018; 41(3):117-121. PubMed ID: 29485414
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
